220 related articles for article (PubMed ID: 38164114)
1. Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics.
Zhang CX; Conrad TM; Hermann D; Gordon MA; Houpt E; Iroh Tam PY; Jere KC; Nedi W; Operario DJ; Phulusa J; Quinnan GV; Sawyer LA; Barrett LK; Thole H; Toto N; Van Voorhis WC; Arnold SLM
CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):410-423. PubMed ID: 38164114
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
[TBL] [Abstract][Full Text] [Related]
3. Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial.
Iroh Tam P; Arnold SLM; Barrett LK; Chen CR; Conrad TM; Douglas E; Gordon MA; Hebert D; Henrion M; Hermann D; Hollingsworth B; Houpt E; Jere KC; Lindblad R; Love MS; Makhaza L; McNamara CW; Nedi W; Nyirenda J; Operario DJ; Phulusa J; Quinnan GV; Sawyer LA; Thole H; Toto N; Winter A; Van Voorhis WC
Clin Infect Dis; 2021 Jul; 73(2):183-191. PubMed ID: 32277809
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
[TBL] [Abstract][Full Text] [Related]
5. The Clofazimine for Treatment of Cryptosporidiosis in HIV-Infected Adults (CRYPTOFAZ) and Lessons Learned for Anticryptosporidial Drug Development.
Huston CD
Clin Infect Dis; 2021 Jul; 73(2):192-194. PubMed ID: 32277815
[No Abstract] [Full Text] [Related]
6. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid.
Nix DE; Adam RD; Auclair B; Krueger TS; Godo PG; Peloquin CA
Tuberculosis (Edinb); 2004; 84(6):365-73. PubMed ID: 15525560
[TBL] [Abstract][Full Text] [Related]
9. Novel treatment strategies and drugs in development for cryptosporidiosis.
Chavez MA; White AC
Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
[TBL] [Abstract][Full Text] [Related]
10. Conducting clinical trials in sub-Saharan Africa: challenges and lessons learned from the Malawi Cryptosporidium study.
Toto N; Douglas E; Gmeiner M; Barrett LK; Lindblad R; Makhaza L; Nedi W; Phulusa J; Quinnan GV; Sawyer LA; Thole H; Van Voorhis WC; Iroh Tam PY
Trials; 2020 Jul; 21(1):680. PubMed ID: 32711568
[TBL] [Abstract][Full Text] [Related]
11. Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study.
Mouly S; Aymard G; Tillement JP; Caulin C; Bergmann JF; Urien S
Br J Clin Pharmacol; 2001 Jun; 51(6):557-65. PubMed ID: 11422015
[TBL] [Abstract][Full Text] [Related]
12. Enteric cryptosporidiosis in pediatric HIV infection.
Guarino A; Castaldo A; Russo S; Spagnuolo MI; Canani RB; Tarallo L; DiBenedetto L; Rubino A
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):182-7. PubMed ID: 9252905
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
de Winter BC; van Gelder T; Glander P; Cattaneo D; Tedesco-Silva H; Neumann I; Hilbrands L; van Hest RM; Pescovitz MD; Budde K; Mathot RA
Clin Pharmacokinet; 2008; 47(12):827-38. PubMed ID: 19026038
[TBL] [Abstract][Full Text] [Related]
14. Treatment of human intestinal cryptosporidiosis: A review of published clinical trials.
Diptyanusa A; Sari IP
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():128-138. PubMed ID: 34562754
[TBL] [Abstract][Full Text] [Related]
15. Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.
Bednasz CJ; Venuto CS; Ma Q; Daar ES; Sax PE; Fischl MA; Collier AC; Smith KY; Tierney C; Acosta EP; Mager DE; Morse GD;
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642925
[TBL] [Abstract][Full Text] [Related]
16. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
Kappelhoff BS; Huitema AD; Yalvaç Z; Prins JM; Mulder JW; Meenhorst PL; Beijnen JH
Clin Pharmacokinet; 2005; 44(8):849-61. PubMed ID: 16029069
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
Zhao W; Cella M; Della Pasqua O; Burger D; Jacqz-Aigrain E;
Br J Clin Pharmacol; 2012 Apr; 73(4):641-50. PubMed ID: 21988586
[TBL] [Abstract][Full Text] [Related]
19. Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy.
Wang RJ; Li JQ; Chen YC; Zhang LX; Xiao LH
Acta Trop; 2018 Nov; 187():257-263. PubMed ID: 30118699
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
